Return to Case Library
Case Preview

Case Intro

Your client is RheumaRelief (RR), a biotechnology company that sells RheumRight, a medicine that treats Rheumatoid Arthritis (RA).

RA is an autoimmune disease that inflames and attacks the joints. If left untreated, it can lead to debilitating pain, bone and joint erosion.

RheumRight slows the progression of RA and is a popular treatment of healthcare provider and patient choice.

After a year of rampant economic inflation, the CFO of RR wants to know if taking a price increase on RheumRight makes sense.

What should the CFO consider?

Return to Case Library

There is no substitute for quality case prep

Access 500+ consulting cases (including answers) that represent 25+ firm styles and 4 levels of difficulty - all for one low price.

Already purchased the Case Library? You'll probably need to log in to your account first.